Roche reveal benefits of Xenical for type 2 diabetics

Publisher： Elsevier

E-ISSN： 1879-3061|12|9|381-381

ISSN： 1043-2760

Source： Trends in Endocrinology and Metabolism, Vol.12, Iss.9, 2001-11, pp. : 381-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cardiac Tests in Asymptomatic Type 2 Diabetics

Medical Principles and Practice, Vol. 11, Iss. 4, 2002-11 ,pp. : 171-175

Karger

Access to resources Recommend Favorite

Poor lipid control in type-2 diabetics with and without ischemic heart disease

By Akbar Daad Al-Gamdi Aish Hejazi Nariman

Endocrine Journal, Vol. 21, Iss. 3, 2003-08 ,pp. : 217-220

Humana Press, Inc

Access to resources Recommend Favorite

Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome

By Akbar Daad

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 215-218

Humana Press, Inc

Access to resources Recommend Favorite

A Community-Based Epidemiologic Study on Gallstone Disease among Type 2 Diabetics in Kinmen, Taiwan

Digestive Diseases, Vol. 22, Iss. 1, 2004-08 ,pp. : 87-91

Karger

Access to resources Recommend Favorite

The `collateral benefits` of noninsulin therapies for Type 2 diabetes

By Roe Erin D Pon Natalie C Hollander Priscilla Raskin Philip

Diabetes Management, Vol. 3, Iss. 2, 2013-03 ,pp. : 145-160

Future Medicine

Access to resources Recommend Favorite